164 related articles for article (PubMed ID: 25506794)
1. Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice.
Rantala J; Kemppainen S; Ndode-Ekane XE; Lahtinen L; Bolkvadze T; Gurevicius K; Tanila H; Pitkänen A
Epilepsy Behav; 2015 Jan; 42():117-28. PubMed ID: 25506794
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of urokinase-type plasminogen activator and its receptor affects social behavior and increases seizure susceptibility.
Kyyriäinen J; Bolkvadze T; Koivisto H; Lipponen A; Pérez LO; Ekolle Ndode-Ekane X; Tanila H; Pitkänen A
Epilepsy Res; 2019 Mar; 151():67-74. PubMed ID: 30836238
[TBL] [Abstract][Full Text] [Related]
3. Epileptogenesis after traumatic brain injury in Plaur-deficient mice.
Bolkvadze T; Puhakka N; Pitkänen A
Epilepsy Behav; 2016 Jul; 60():187-196. PubMed ID: 27208924
[TBL] [Abstract][Full Text] [Related]
4. Epileptogenesis after traumatic brain injury in Plau-deficient mice.
Bolkvadze T; Rantala J; Puhakka N; Andrade P; Pitkänen A
Epilepsy Behav; 2015 Oct; 51():19-27. PubMed ID: 26253597
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2845-52. PubMed ID: 21868698
[TBL] [Abstract][Full Text] [Related]
6. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.
Gyetko MR; Aizenberg D; Mayo-Bond L
J Leukoc Biol; 2004 Sep; 76(3):648-56. PubMed ID: 15240745
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.
Reichel CA; Uhl B; Lerchenberger M; Puhr-Westerheide D; Rehberg M; Liebl J; Khandoga A; Schmalix W; Zahler S; Deindl E; Lorenzl S; Declerck PJ; Kanse S; Krombach F
Circulation; 2011 Oct; 124(17):1848-59. PubMed ID: 21969013
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy.
Ndode-Ekane XE; Pitkänen A
Mol Neurobiol; 2013 Jun; 47(3):914-37. PubMed ID: 23263886
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
Bai X; Weitz JI; Gross PL
Thromb Haemost; 2009 Dec; 102(6):1212-8. PubMed ID: 19967153
[TBL] [Abstract][Full Text] [Related]
12. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.
Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W
FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus.
Lahtinen L; Ndode-Ekane XE; Barinka F; Akamine Y; Esmaeili MH; Rantala J; Pitkänen A
Neurobiol Dis; 2010 Mar; 37(3):692-703. PubMed ID: 20026272
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
[TBL] [Abstract][Full Text] [Related]
15. Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA.
Gyetko MR; Sud S; Sonstein J; Polak T; Sud A; Curtis JL
J Immunol; 2001 Nov; 167(10):5539-42. PubMed ID: 11698423
[TBL] [Abstract][Full Text] [Related]
16. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
Shanmukhappa K; Sabla GE; Degen JL; Bezerra JA
BMC Gastroenterol; 2006 Nov; 6():40. PubMed ID: 17134505
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by urokinase plasminogen activator in the hippocampus.
Cho E; Lee KJ; Seo JW; Byun CJ; Chung SJ; Suh DC; Carmeliet P; Koh JY; Kim JS; Lee JY
Neurobiol Dis; 2012 Apr; 46(1):215-24. PubMed ID: 22293605
[TBL] [Abstract][Full Text] [Related]
20. The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung.
Shushakova N; Eden G; Dangers M; Menne J; Gueler F; Luft FC; Haller H; Dumler I
J Immunol; 2005 Sep; 175(6):4060-8. PubMed ID: 16148155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
